Literature DB >> 11882762

Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver.

Hannes A Rüdiger1, Koo J Kang, David Sindram, Hans M Riehle, Pierre A Clavien.   

Abstract

OBJECTIVE: To compare protection of the liver by ischemic preconditioning and intermittent inflow occlusion in a mouse model of prolonged periods of ischemia. SUMMARY BACKGROUND DATA: Preconditioning (short ischemic stress prior to a prolonged period of ischemia) and intermittent inflow occlusion protect the liver against reperfusion injury. This is the first study comparing these two modalities with continuous inflow occlusion (control).
METHODS: Mice were subjected to 75 or 120 minutes of 70% hepatic ischemia and 3 hours of reperfusion. Each ischemic period was evaluated using three different protocols: continuous ischemia (control), preconditioning (10 minutes ischemia and 15 minutes reperfusion) prior to the prolonged ischemic insult, and intermittent clamping (cycles of 15 minutes ischemia and 5 minutes reperfusion). Organ injury was evaluated using serum levels of aspartate aminotransferase (AST), hematoxylin and eosin staining, and specific markers of apoptosis (cytochrome C release, caspase 3 activity, and TUNEL staining). Animal survival was determined using a model of total hepatic ischemia.
RESULTS: Intermittent inflow occlusion and ischemic preconditioning were both protective against ischemic insults of 75 and 120 minutes compared with controls (continuous ischemia only). Protection against 75 minutes of ischemia was comparable in the intermittent clamping and the ischemic preconditioning group, whereas intermittent clamping was superior at 120 minutes of ischemia. One hundred percent animal survival was observed after 75 minutes of total hepatic ischemia using both protective protocols, whereas all animals subjected to continuous ischemia died after surgery. After 120 minutes of ischemia, intermittent inflow occlusion was associated with better animal survival (71%) compared with preconditioning (14%).
CONCLUSIONS: Preconditioning and intermittent clamping are both protective against prolonged periods of ischemia. In the clinical setting, preconditioning is superior for ischemic periods of up to 75 minutes because it is not associated with blood loss during transection of the liver. However, for prolonged ischemic insults exceeding 75 minutes, intermittent clamping is superior to preconditioning.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11882762      PMCID: PMC1422446          DOI: 10.1097/00000658-200203000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  46 in total

Review 1.  A cytotoxic drug against reperfusion injury?

Authors:  H A Rüdiger; P A Clavien
Journal:  Hepatology       Date:  2000-02       Impact factor: 17.425

2.  Preconditioning for protection from ischemic injury: discriminating cause from effect from epiphenomenon.

Authors:  G B Bulkley
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

3.  Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis.

Authors:  V Kohli; J F Madden; R C Bentley; P A Clavien
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

4.  Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver.

Authors:  D Sindram; R J Porte; M R Hoffman; R C Bentley; P A Clavien
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

5.  Safety of hemihepatic vascular occlusion during resection of the liver.

Authors:  M Makuuchi; T Mori; P Gunvén; S Yamazaki; H Hasegawa
Journal:  Surg Gynecol Obstet       Date:  1987-02

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  An analysis of 412 cases of hepatocellular carcinoma at a Western center.

Authors:  Y Fong; R L Sun; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

8.  Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism.

Authors:  S Natori; M Selzner; K L Valentino; L C Fritz; A Srinivasan; P A Clavien; G J Gores
Journal:  Transplantation       Date:  1999-07-15       Impact factor: 4.939

9.  Continuous versus intermittent portal triad clamping for liver resection: a controlled study.

Authors:  J Belghiti; R Noun; R Malafosse; P Jagot; A Sauvanet; F Pierangeli; J Marty; O Farges
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

10.  Prolonged intermittent clamping of the portal triad during hepatectomy.

Authors:  D Elias; E Desruennes; P Lasser
Journal:  Br J Surg       Date:  1991-01       Impact factor: 6.939

View more
  27 in total

Review 1.  Protection of the liver during hepatic surgery.

Authors:  Pierre-Alain Clavien; Jean Emond; Jean Nicolas Vauthey; Jacques Belghiti; Ravi S Chari; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

Review 2.  How much ischemia can the liver tolerate during resection?

Authors:  Wouter G van Riel; Rowan F van Golen; Megan J Reiniers; Michal Heger; Thomas M van Gulik
Journal:  Hepatobiliary Surg Nutr       Date:  2016-02       Impact factor: 7.293

3.  Ischemic preconditioning versus intermittent vascular inflow control during major liver resection in pigs.

Authors:  Vassilios Smyrniotis; Georgia Kostopanagiotou; Kassiani Theodoraki; Charalampos Farantos; Nikolaos Arkadopoulos; Evangelos Gamaletsos; Agathi Condi-Paphitis; Alexis Fotopoulos; Panagiotis Dimakakos
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

4.  Intermittent clamping is superior to ischemic preconditioning and its effect is more marked with shorter clamping cycles in the rat liver.

Authors:  Yasuji Seyama; Hiroshi Imamura; Yoshinori Inagaki; Yutaka Matsuyama; Wei Tang; Masatoshi Makuuchi; Norihiro Kokudo
Journal:  J Gastroenterol       Date:  2012-06-16       Impact factor: 7.527

Review 5.  Hemihepatic versus total hepatic inflow occlusion during hepatectomy: a systematic review and meta-analysis.

Authors:  Hai-Qing Wang; Jia-Yin Yang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

6.  Colorectal liver metastasis surgery: analysis of risk factors predicting postoperative complications in relation to the extent of resection.

Authors:  Ralf Konopke; Stephan Kersting; Alfred Bunk; Janine Dietrich; Axel Denz; Jörg Gastmeier; Hans-Detlev Saeger
Journal:  Int J Colorectal Dis       Date:  2009-02-13       Impact factor: 2.571

7.  Signs of reperfusion injury following CO2 pneumoperitoneum: an in vivo microscopy study.

Authors:  Arash Nickkholgh; Miriam Barro-Bejarano; Rui Liang; Markus Zorn; Arianeb Mehrabi; Martha-Maria Gebhard; Markus W Büchler; Carsten N Gutt; Peter Schemmer
Journal:  Surg Endosc       Date:  2007-05-05       Impact factor: 4.584

8.  Ischemic preconditioning confers antiapoptotic protection during major hepatectomies performed under combined inflow and outflow exclusion of the liver. A randomized clinical trial.

Authors:  Nikolaos Arkadopoulos; Georgia Kostopanagiotou; Kassiani Theodoraki; Charalambos Farantos; Theodosios Theodosopoulos; Vaia Stafyla; John Vassiliou; Dionyssios Voros; Agathi Pafiti; Vassilios Smyrniotis
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

9.  Complex hepatectomy under total vascular exclusion of the liver: impact of ischemic preconditioning on clinical outcomes.

Authors:  Jangyong Jeon; Anthony Watkins; Gebhard Wagener; Benjamin Samstein; James Guarrera; Michael Goldstein; Joseph Meltzer; Tomoaki Kato; Jean C Emond
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

Review 10.  Role of ischemic preconditioning in liver surgery and hepatic transplantation.

Authors:  Eduardo E Montalvo-Jave; Enrique Piña; Cesar Montalvo-Arenas; Raúl Urrutia; Luis Benavente-Chenhalls; Julieta Peña-Sanchez; David A Geller
Journal:  J Gastrointest Surg       Date:  2009-04-30       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.